Samsara BioCapital’s Albireo Pharma Inc ALBO Stock Holding History

Samsara BioCapital’s Portfolio ALBO Stock Details ALBO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-100,000	Closed	-$2.16M	–	59
2022 Q4	$2.16M	Hold	100,000	–	–	0.47%	31
2022 Q3	$1.94M	Hold	100,000	–	–	0.45%	36
2022 Q2	$1.99M	Hold	100,000	–	–	0.53%	35
2022 Q1	$2.98M	Hold	100,000	–	–	0.75%	31
2021 Q4	$2.33M	Hold	100,000	–	–	0.45%	33
2021 Q3	$3.12M	Hold	100,000	–	–	0.49%	33
2021 Q2	$3.52M	Hold	100,000	–	–	0.43%	34
2021 Q1	$3.52M	Hold	100,000	–	–	0.65%	33
2020 Q4	$3.75K	Hold	100,000	–	–	0.38%	25
2020 Q3	$3.34M	Buy	+100,000	New	+$2.91M	0.93%	22

Other funds holding ALBO

DekaBank Deutsche Girozentrale Frankfurt, Germany $60.6B AUM 23.27% 1-Year Est. Return

GKIM

GW&K Investment Management Boston, Massachusetts $11.3B AUM 31.98% 1-Year Est. Return

HNB

Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Samsara BioCapital's ALBO Position: Q1 2023 in Review

Samsara BioCapital sold out of Albireo Pharma Inc (ALBO) in Q1 2023, closing a stake of 100,000 shares — an estimated $2.16M sold.

Samsara BioCapital first reported a position in ALBO in Q3 2020 and held it in 10 quarters. The position peaked at $3.52M in Q1 2021. 3 funds tracked by Wall St. Rank hold ALBO as of Q1 2023.

Samsara BioCapital reported no remaining Albireo Pharma Inc position as of Q1 2023 after selling out during the quarter.
Samsara BioCapital sold 100,000 Albireo Pharma Inc shares in Q1 2023, an estimated $2.16M.
Samsara BioCapital first reported a position in Albireo Pharma Inc in Q3 2020 and held it in 10 quarters.
Samsara BioCapital's Albireo Pharma Inc position peaked at $3.52M in Q1 2021.
3 funds tracked by Wall St. Rank held Albireo Pharma Inc as of Q1 2023.

Based on Samsara BioCapital's 13F filing for Q1 2023, filed 15 May 2023.